ACUTE MYELOBLASTIC-LEUKEMIA (ANLL-M2) WITH T(8-21)(Q22-Q22) VARIANT EXPRESSING LYMPHOID BUT NOT MYELOID SURFACE-ANTIGENS WITH A HIGH NUMBEROF G-CSF RECEPTORS
H. Tsuchiya et al., ACUTE MYELOBLASTIC-LEUKEMIA (ANLL-M2) WITH T(8-21)(Q22-Q22) VARIANT EXPRESSING LYMPHOID BUT NOT MYELOID SURFACE-ANTIGENS WITH A HIGH NUMBEROF G-CSF RECEPTORS, Leukemia research, 17(4), 1993, pp. 375-377
Leukemic cells from an 8-year-old girl with ANLL-M2 expressed precurso
r B-cell antigen CD19, but none of the myeloid antigens CD11b, CD13, C
D14 and CD33. After culture, the cells expressed CD11b and CD13. The c
ells carried a high number of granulocyte colony-stimulating factor (G
-CSF) receptors. In chromosome analysis, metaphase cells were obtained
only in the case of culture with G-CSF. The karyotype was a variant o
f t(8;21)(q22;q22). Southern blot analysis revealed rearrangement of t
he AML1 gene located on chromosome 21. These observations may suggest
that even without myeloid surface antigens and with precursor B-cell a
ntigen, ANLL-M2 with t(8;21)(q22;q22) has apparent myeloid characteris
tics.